Publications

1-(3-Chlorophenyl)-2-(methylamino) propan-1-one (3-chloromethcathinone, 3-CMC) is a synthetic cathinone stimulant. It is a ring-substituted cathinone, which is structurally related to methcathinone and 4-chloromethcathinone (4-CMC).

The initial report is submitted to the Commission and the Member States.

Abstract

Background: Addictology is a transdisciplinary field dealing with the treatment andprevention of addictions. As yet the field does not have a document describing the competencies of graduates of its dedicated academic programme which would clearly define their professional boundaries and interface with other related disciplines.

What do we mean by evidence and why does it matter?

This article, published by Drugs Research Network Scotland, discusses the hierarchy of evidence and the way evidence can be used to inform effective and efficient drug policy and practice.

The blog post explores the different types of research that exist within the evidence pyramid and highlights the reasons why evidence is helpful within our practice.

NGO CIVIL SOCIETY SUBMISSION TO WHO-SAFER MISSION on Alcohol in Uganda

compiled by:

Uganda Alcohol Policy Alliance (UAPA)

                     and

Uganda Youth Development Link (UYDEL)

Kampala - Uganda. 24 November 2021

Documento del Ministerio de Salud y Protección Social de Colombia que presenta línea de base de los programas de mantenimiento con metadona en el país y el perfil de la población atendidas y las características generales del tratamiento, así como recomendaciones en salud pública para el fortalecimiento de estos programas.

Supply reduction is often the main approach used for addressing the illicit drug problem.

Evaluation is an integral part of a good governance approach to public policy. This principle applies equally to the component of drug policy designed to counter the availability of and access to illicit drugs. Estimation or full costing of drug-related public investment – including both direct expenditure and also indirect costs and impact on public resources – should therefore be a key objective of any evaluation.

دا برېګمینګ د الکولو د انرژۍ ( کالری ) لیبل نګولو په اړه شته شواهد ، د تېرو پنځو کلونو ( ۲۰۱۶ - ۲۰۲۱ ) په بهیر کې ترکیبوی .

دا معلومات په علمی ادبیاتو کې د الکولو د انرژۍ د لیبل کولو د اغیز ، مطالعې او نظر ورکولو په شاوخوا کې د خلکو د ملاتړ په اړه د انرژۍ د لیبل کولو ، د کالورۍ نه بهر د انرژۍ د لیبل کولو لپاره بدیلې لارې او د الکولو د لیبل کولو لپاره پراخ انتخابونه تر پوښښ لاندې راولی کوم چې کولی شی د الکولو زیان په ګوته کړی.

This report, published by UNODC, highlights the latest findings and emerging trends relating to the drug situation in Afghanistan.

The WHO Expert Committee on Drug Dependence defines treatment as the process that begins when psychoactive substance users contact a health provider or other community service and may continue through a succession of specific interventions until the highest attainable level of health and well-being is reached.

The Substance Abuse and Mental Health Services Administration (SAMHSA) has identified many well-researched drug-free workplace programs and published "A Kit for Employers: Making the workplace drug free".

This Employer kit describes the below:

EMCDDA has published Policy and practice briefings in Workplaces. This policy and practice briefing provides an overview of the key issues, response options, evidence and implications for policy and practice.

In the 1990s, new addiction services began to emerge that had a shortage of appropriately qualified and trained practitioners. This impulse led to the establishment of the health profession of an ADDICTOLOGIST in the Czech Republic. In the course of time, this new profession was developed and gave rise to an original and unique concept of the study program.